CMTU
TEVA icon

Capital Markets Trading (UK)’s Teva Pharmaceuticals TEVA Stock Holding History

Capital Markets Trading (UK)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-164,291
Closed -$5.47M – 380
2026
Q1 		$4.95M Buy
164,291
+104,690
+176% +$3.37M 0.06% 153
2025
Q4 		$1.86M Sell
59,601
-40,297
-40% -$993K 0.03% 212
2025
Q3 		$2.02M Sell
99,898
-136,318
-58% -$2.39M 0.03% 206
2025
Q2 		$3.96M Buy
236,216
+189,245
+403% +$3.05M 0.07% 167
2025
Q1 		$722K Sell
46,971
-457,001
-91% -$8.16M 0.01% 244
2024
Q4 		$11.1M Buy
503,972
+137,298
+37% +$2.5M 0.17% 118
2024
Q3 		$6.61M Sell
366,674
-80,735
-18% -$1.41M 0.09% 148
2024
Q2 		$7.27M Buy
447,409
+328,159
+275% +$5.05M 0.11% 135
2024
Q1 		$1.68M Buy
119,250
+18,402
+18% +$232K 0.02% 208
2023
Q4 		$1.05M Sell
100,848
-33,767
-25% -$315K 0.01% 218
2023
Q3 		$1.37M Buy
+134,615
New +$1.25M 0.02% 217
2023
Q1 		– Sell
-258,241
Closed -$2.55M – 281
2022
Q4 		$2.35M Sell
258,241
-506,623
-66% -$4.42M 0.05% 137
2022
Q3 		$6.17M Buy
764,864
+683,013
+834% +$6.04M 0.13% 101
2022
Q2 		$616K Sell
81,851
-63,395
-44% -$552K 0.01% 185
2022
Q1 		$1.36M Sell
145,246
-1,003,223
-87% -$8.37M 0.02% 169
2021
Q4 		$9.2M Buy
1,148,469
+412,137
+56% +$3.72M 0.12% 85
2021
Q3 		$7.34M Sell
736,332
-32,797
-4% -$307K 0.1% 98
2021
Q2 		$7.61M Buy
769,129
+509,589
+196% +$5.39M 0.12% 91
2021
Q1 		$3M Buy
259,540
+69,836
+37% +$801K 0.05% 129
2020
Q4 		$1.83M Sell
189,704
-115,282
-38% -$1.1M 0.02% 138
2020
Q3 		$2.83M Buy
304,986
+233,051
+324% +$2.47M 0.04% 122
2020
Q2 		$887K Buy
+71,935
New +$814K 0.02% 148
2019
Q4 		– Sell
-95,563
Closed -$853K – 205
2019
Q3 		$657K Sell
95,563
-46,780
-33% -$358K 0.03% 170
2019
Q2 		$1.31M Buy
142,343
+117,656
+477% +$1.42M 0.06% 149
2019
Q1 		$387K Buy
24,687
+5,651
+30% +$99.7K 0.02% 159
2018
Q4 		$294K Sell
19,036
-6,336
-25% -$130K 0.02% 172
2018
Q3 		$547K Buy
25,372
+7,320
+41% +$170K 0.03% 160
2018
Q2 		$439K Buy
+18,052
New +$368K 0.02% 165
2018
Q1 		– Sell
-10,949
Closed -$214K – 183
2017
Q4 		$207K Buy
+10,949
New +$165K 0.01% 158

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Capital Markets Trading (UK)'s TEVA Position: Q2 2026 in Review

Capital Markets Trading (UK) sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 164,291 shares — an estimated $5.47M sold.

Capital Markets Trading (UK) first reported a position in TEVA in Q4 2017 and held it in 29 quarters. The position peaked at $11.1M in Q4 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Capital Markets Trading (UK) reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Capital Markets Trading (UK) sold 164,291 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.47M.
  • Capital Markets Trading (UK) first reported a position in Teva Pharmaceuticals in Q4 2017 and held it in 29 quarters.
  • Capital Markets Trading (UK)'s Teva Pharmaceuticals position peaked at $11.1M in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Capital Markets Trading (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.